Treatment for more Australians living with myeloma now available through Pharmaceutical Benefits Scheme (PBS)
- Advocacy and policy
- Media releases
- Myeloma
The Pharmaceutical Benefits Advisory Committee (PBAC) considered four blood cancer treatments at its March 2020 meeting including a drug for myeloma – plitidepsin (Aplidin®).
The Leukaemia Foundation welcomes the commitment from the Federal Health Minister Greg Hunt to establish a Blood Cancer Taskforce and Action Plan.